Atrial stunning: basics and clinical considerations

Area of Science:

• Cardiology
• Electrophysiology

Background:

• Atrial fibrillation and flutter conversion to sinus rhythm can cause transient atrial mechanical dysfunction, known as atrial stunning.
• This phenomenon is observed across all cardioversion modalities, including electrical, pharmacological, and ablation-based methods.

Purpose of the Study:

• To define atrial stunning, its mechanisms, clinical implications, and potential therapeutic interventions.
• To elucidate the relationship between atrial stunning duration and patient outcomes, including thromboembolism and functional recovery.

Main Methods:

• Review of existing literature on atrial stunning following cardioversion for atrial fibrillation and flutter.
• Analysis of proposed mechanisms, including tachycardia-induced atrial cardiomyopathy, calcium overload, and atrial hibernation.
• Examination of clinical consequences such as postcardioversion thromboembolism and impaired cardiac output.

Main Results:

• Atrial stunning is a direct consequence of the arrhythmia becoming apparent upon sinus rhythm restoration, not the conversion method itself.
• The severity and duration of stunning vary based on atrial fibrillation duration, heart structure, and atrial size, resolving within minutes to weeks.
• Atrial stunning is linked to postcardioversion thromboembolism and delayed functional recovery, with differential impact on right and left atria.

Conclusions:

• Atrial stunning is an inherent complication of successful cardioversion, influencing patient management and recovery.
• Anticoagulation duration post-cardioversion should be guided by the resolution timeline of atrial stunning.
• Investigating protective agents like verapamil and isoproterenol may mitigate atrial stunning effects.